Valuation
Medical DevicesLive · Yahoo FinancePrice
$152.97
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
SWOT Analysis — BDX
Inflationary BoomStrengths
Gross Profit: $7.6B (+283.1% YoY) — Gross profit rose 283% — the spread between revenue and direct costs improved.
Operating Cash Flow: $4.6B (+31.3% YoY) — Operating cash flow grew 31% — the business generated more cash from day-to-day operations.
Revenue: $21.8B (+8.2% YoY) — Revenue grew 8% — the company sold more goods or services than the prior year.
Weaknesses
Total Assets: $55.3B (-3.4% YoY) — Total assets shrank 3% — the balance sheet contracted.
Net Income: $1.7B (-1.6% YoY) — Profit fell 2% but remained positive.
Opportunities
No clear opportunities identified at this time.
Threats
Current ratio of 1.11x — thin liquidity buffer against short-term obligations.
Financial Charts
Year-over-Year Changes
Gross Profit
$7.6B
was $2.0B
Gross profit rose 283% — the spread between revenue and direct costs improved.
Operating Cash Flow
$4.6B
was $3.5B
Operating cash flow grew 31% — the business generated more cash from day-to-day operations.
Revenue
$21.8B
was $20.2B
Revenue grew 8% — the company sold more goods or services than the prior year.
Total Assets
$55.3B
was $57.3B
Total assets shrank 3% — the balance sheet contracted.
Net Income
$1.7B
was $1.7B
Profit fell 2% but remained positive.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Current ratio of 1.11x — thin liquidity buffer against short-term obligations.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade BDX
Links open broker research pages. Not an endorsement or recommendation.
Research BECTON, DICKINSON AND COMPANY
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.